Increased risk of solid renal tumors in lithium-treated patients

Kidney International

Volumn 86, Issue 1, 2014, Pages 184-190

  Zaidan, Mohamad ^a,b,c   Stucker, Fabien ^d   Stengel, Bénédicte ^e   Vasiliu, Viorel ^a   Hummel, Aurélie ^a,b   Landais, Paul ^a,b   Boffa, Jean Jacques ^d,f   Ronco, Pierre ^d,f   Grünfeld, Jean Pierre ^a,b   Servais, Aude ^a,b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d HÔPITAL TENON   (France)

^e CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^f SORBONNE UNIVERSITÉ   (France)

Author keywords

lithium; nephrotoxicity; oncocytoma; renal cancer; renal tumors

Indexed keywords

LITHIUM; LITHIUM DERIVATIVE; TRANQUILIZER;

ADULT; AGED; ANGIOMYOLIPOMA; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY CARCINOMA; KIDNEY CYST; KIDNEY TUMOR; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; ONCOCYTOMA; PAPILLARY RENAL CELL CARCINOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX RATIO; STANDARDIZED INCIDENCE RATIO; TREATMENT DURATION; ADENOMA, OXYPHILIC; BIPOLAR DISORDER; CARCINOMA, RENAL CELL; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; COMPLICATION; FRANCE; INCIDENCE; KIDNEY NEOPLASMS; MIDDLE AGED; PATHOLOGY; RISK FACTOR; TIME FACTOR;

ADENOMA, OXYPHILIC; ADULT; ANGIOMYOLIPOMA; ANTIMANIC AGENTS; BIPOLAR DISORDER; CARCINOMA, RENAL CELL; COHORT STUDIES; FEMALE; FRANCE; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84903776646     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.2     Document Type: Article

References (45)

1. Muller-Oerlinghausen B, Berghofer A, Bauer M. Bipolar disorder. Lancet 2002; 359: 241-247. (Pubitemid 34113827)
2. Grunfeld JP, Rossier BC. Lithium nephrotoxicity revisited. Nat Rev Nephrol 2009; 5: 270-276.
3. Walker RG, Escott M, Birchall I et al. Chronic progressive renal lesions induced by lithium. Kidney Int 1986; 29: 875-881. (Pubitemid 16094016)
4. Bendz H, Aurell M, Lanke J. A historical cohort study of kidney damage in long-Term lithium patients: Continued surveillance needed. Eur Psychiatry 2001; 16: 199-206. (Pubitemid 32591790)
5. Presne C, Fakhouri F, Noe?l LH et al. Lithium-induced nephropathy: Rate of progression and prognostic factors. Kidney Int 2003; 64: 585-592. (Pubitemid 36871930)
6. Bassilios N, Martel P, Godard V et al. Monitoring of glomerular filtration rate in lithium-Treated outpatients-An ambulatory laboratory database surveillance. Nephrol Dial Transpl 2008; 23: 562-565. (Pubitemid 351767609)
7. Markowitz GS, Radhakrishnan J, Kambham N et al. Lithium nephrotoxicity: A progressive combined glomerular and tubulointerstitial nephropathy. J Am Soc Nephrol 2000; 11: 1439-1448. (Pubitemid 30483460)
8. Kjaersgaard G, Madsen K, Marcussen N et al. Tissue injury after lithium treatment in human and rat postnatal kidney involves glycogen synthase kinase-3b-positive epithelium. Am J Physiol Ren Physiol 2012; 302: F455-F465.
9. Rookmaaker MB, Gerven HAJM van, Goldschmeding R et al. Solid renal tumours of collecting duct origin in patients on chronic lithium therapy. Clin. Kidney J 2012; 5: 412-415.
10. Zardawi I, Nagonkar S, Patel P. Renal cell carcinoma in a setting of chronic lithium toxicity. Am J Case Rep 2013; 14: 300-303.
11. Marple JT, MacDougall M, Chonko AM. Renal cancer complicating acquired cystic kidney disease. J Am Soc Nephrol 1994; 4: 1951-1956.
12. Lornoy W, Becaus S, de Vleeschouwer M et al. Renal cell carcinoma, a new complication of analgesic nephropathy. Lancet 1986; 1: 1271-1272. (Pubitemid 16112323)
13. Nortier JL, Martinez MC, Schmeiser HH et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000; 342: 1686-1692. (Pubitemid 30354515)
14. Farres MT, Ronco P, Saadoun D et al. Chronic lithium nephropathy: MR imaging for diagnosis. Radiology 2003; 229: 570-574. (Pubitemid 37310848)
15. Amin MB, Tamboli P, Javidan J et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: An experience of 405 cases. Am J Surg Pathol 2002; 26: 281-291. (Pubitemid 34184451)
16. Lopez-Beltran A, Scarpelli M, Montironi R et al. 2004 WHO classification of the renal tumors of the adults. Eur Urol 2006; 49: 798-805.
17. Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med 2005; 353: 2477-2490. (Pubitemid 41770167)
18. Tickoo SK, dePeralta-Venturina MN, Harik LR et al. Spectrum of epithelial neoplasms in end-stage renal disease: An experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 2006; 30: 141-153. (Pubitemid 43740182)
19. Bonsib SM. Renal cystic diseases and renal neoplasms: A mini-review. Clin J Am Soc Nephrol 2009; 4: 1998-2007.
20. Bausch B, Jilg C, Gläsker S et al. Renal cancer in von Hippel-Lindau disease and related syndromes. Nat Rev Nephrol 2013; 9: 529-538.
21. Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med 2006; 355: 1345-1356.
22. Kuroda N, Toi M, Hiroi M et al. Review of renal oncocytoma with focus on clinical and pathobiological aspects. Histol Histopathol 2003; 18: 935-942. (Pubitemid 36773237)
23. Kuroda N, Tanaka A, Ohe C et al. Review of renal oncocytosis (multiple oncocytic lesions) with focus on clinical and pathobiological aspects. Histol Histopathol 2012; 27: 1407-1412.
24. Christensen BM, Zuber AM, Loffing J et al. alphaENaC-mediated lithium absorption promotes nephrogenic diabetes insipidus. J Am Soc Nephrol 2011; 22: 253-261.
25. Nielsen J, Hoffert JD, Knepper MA et al. Proteomic analysis of lithiuminduced nephrogenic diabetes insipidus: Mechanisms for aquaporin 2 down-regulation and cellular proliferation. Proc Natl Acad Sci USA 2008; 105: 3634-3639. (Pubitemid 351723604)
26. Cantero MeR, Cantiello HF. Effect of lithium on the electrical properties of polycystin-2 (TRPP2). Eur Biophys J 2011; 40: 1029-1042.
27. Pap M, Cooper GM. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway. J Biol Chem 1998; 273: 19929-19932. (Pubitemid 28377539)
28. Sinha D, Wang Z, Ruchalski KL et al. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors. Am J Physiol Ren Physiol 2005; 288: F703-F713. (Pubitemid 40381737)
29. Benzing T, Simons M, Walz G. Wnt signaling in polycystic kidney disease. J Am Soc Nephrol 2007; 18: 1389-1398. (Pubitemid 46717505)
30. Lancaster MA, Gleeson JG. Cystic kidney disease: The role of Wnt signaling. Trends Mol Med 2010; 16: 349-360.
31. Thoma CR, Frew IJ, Krek W. The VHL tumor suppressor: Riding tandem with GSK3beta in primary cilium maintenance. Cell Cycle 2007; 6: 1809-1813. (Pubitemid 47327896)
32. Qu Z, Sun D, Young W. Lithium promotes neural precursor cell proliferation: Evidence for the involvement of the non-canonical GSK-3b-NF-AT signaling. Cell Biosci 2011; 1: 18.
33. Network CGAR. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013; 499: 43-49.
34. Sato Y, Yoshizato T, Shiraishi Y et al. Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet 2013; 45: 860-867.
35. Yang OC, Maxwell PH, Pollard PJ. Renal cell carcinoma: Translational aspects of metabolism and therapeutic consequences. Kidney Int 2013; 84: 667-681.
36. Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol 2010; 7: 245-257.
37. Maisonneuve P, Agodoa L, Gellert R et al. Cancer in patients on dialysis for end-stage renal disease: An international collaborative study. Lancet 1999; 354: 93-99. (Pubitemid 29313142)
38. Vajdic CM, McDonald SP, McCredie MR et al. Cancer incidence before and after kidney transplantation. JAMA 2006; 296: 2823-2831. (Pubitemid 44969182)
39. Fried LF, Katz R, Sarnak MJ et al. Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol 2005; 16: 3728-3735. (Pubitemid 46211295)
40. Geddes JR, Miklowitz DJ. Treatment of bipolar disorder. Lancet 2013; 381: 1672-1682.
41. Depp C, Ojeda VD, Mastin W et al. Trends in use of antipsychotics and mood stabilizers among Medicaid beneficiaries with bipolar disorder, 2001-2004. Psychiatr Serv 2008; 59: 1169-1174.
42. Moreno C, Laje G, Blanco C et al. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry 2007; 64: 1032-1039. (Pubitemid 47360848)
43. Patard JJ. Incidental renal tumours. Curr Opin Urol 2009; 19: 454-458.
44. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470. (Pubitemid 29135798)
45. Belot A, Grosclaude P, Bossard N et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 2008; 56: 159-175.